Skip to main content
STRATEC SE logo

STRATEC SE — Investor Relations & Filings

Ticker · SBS ISIN · DE000STRA555 LEI · 529900ZZJWANAFSPGV30 F Manufacturing
Open in API
Filings indexed 828 across all filing types
Latest filing 2016-07-21 Interim / Quarterly Rep…
Country DE Germany
Listing F SBS

About STRATEC SE

https://www.stratec.com/home

STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.

Recent filings

Filing Released Lang Actions
Half-yearly financial report 2016
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Financial Report' and covers the period ending June 30, 2016. It contains comprehensive financial statements, including a Consolidated Balance Sheet, Consolidated Statement of Comprehensive Income, Consolidated Cash Flow Statement, and Notes to the Group Interim Report. It also includes a 'Letter from the Board of Management' and an 'Interim Group Management Report'. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H2 2016
2016-07-21 German
Conference Call Half-yearly Financial Report H1|2016
Investor Presentation Classification · 1% confidence The document is a presentation titled 'H1 2016 Financial Results' for STRATEC, containing financial highlights, tables of key figures (Sales, EBIT, EPS), and strategic outlook. It is structured as a slide deck for an investor audience, which is characteristic of an Investor Presentation. It is not a full interim report (which would be a formal regulatory filing) nor a transcript of a call, but rather the visual materials used to communicate financial performance and strategy to investors. H1 2016
2016-07-21 English
Report Publication Announcement 2016
Report Publication Announcement Classification · 1% confidence The document is very short (1569 characters) and explicitly states that it is a 'Preliminary announcement of the publication of financial reports'. It details *when* and *where* the actual financial reports (specifically a 'Financial report of the group (half-year/Q2)') will be disclosed on July 21, 2016. According to Rule #2 (The 'MENU VS MEAL' Rule), a document announcing the publication of a report, rather than being the report itself, should be classified as a Report Publication Announcement (RPA). The content perfectly matches the description for RPA: 'Announcement regarding the timing, release, or publication of company reports (often stating the report is attached or available on the website)'.
2016-07-13 English
STRATEC completes acquisition of Sony DADC BioSciences
M&A Activity Classification · 1% confidence The document is a news release announcing the successful completion of an acquisition (STRATEC completing the acquisition of Sony DADC BioSciences). It uses keywords like 'DGAP-News', 'Corporate News', and details a significant corporate action (Takeover/Acquisition). This type of announcement, which is not a standard periodic report (10-K, IR, ER) or a specific shareholder/director action, fits best under the general category for corporate announcements or regulatory filings that don't fit elsewhere. Since it is a specific corporate event announcement (M&A activity), the 'TAR' (M&A Activity) code is the most appropriate fit, as it details the finalization of a takeover/acquisition agreement. It is not a proxy statement (DEF 14A), a dividend notice (DIV), or an earnings release (ER). Given the explicit mention of 'Takeover/Acquisition' in the keywords, TAR is selected over the general RNS.
2016-07-01 English
STRATEC Biomedical AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Total Voting Rights Announcement' and explicitly references Article 26a of the WpHG (German Securities Trading Act). It details a 'Type of capital measure' which is a 'Conditional capital increase' and states the 'New total number of voting rights'. This type of announcement, concerning the total number of shares and voting rights, is a specific regulatory disclosure. It does not fit the definition of an Annual Report (10-K), Earnings Release (ER), or a general Investor Presentation (IP). It is a specific regulatory filing related to capital structure changes and voting rights disclosure, which aligns best with the general regulatory filing category (RNS) or potentially a specific capital/financing update (CAP). Given the focus is purely on the total voting rights count following a capital measure, and it is a formal announcement via DGAP (a service for regulatory announcements), RNS (Regulatory Filings) is the most appropriate general classification for this type of mandatory disclosure that isn't covered by a more specific code like DVA (which is for voting *results*). However, since it directly relates to a change in capital structure ('Conditional capital increase'), CAP (Capital/Financing Update) is also highly relevant. Since the core purpose is the formal announcement of the resulting voting rights count, RNS serves as the best fit for a mandatory, non-financial results regulatory notice.
2016-06-30 English
STRATEC Annual General Meeting approves record dividend
AGM Information Classification · 1% confidence The document explicitly mentions 'STRATEC Annual General Meeting approves record dividend' in the headline and body. It discusses shareholder approvals, the election of auditors, and the distribution of a dividend following the 2015 financial year. This content directly relates to the proceedings and outcomes of the Annual General Meeting (AGM). Although it mentions voting results, the primary focus is the meeting itself and the dividend approval, making AGM-R the most appropriate classification over DVA (which focuses only on voting results) or DIV (which focuses only on the dividend amount announcement). Given the length (4248 chars) and content, it is the announcement/summary of the AGM, not just a brief RPA.
2016-06-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.